```html

Quasi‑Immunodeficiency (Selective IgA Deficiency)

Overview

Selective Immunoglobulin A deficiency (SIgAD), often described as “quasi‑immunodeficiency,” is the most common primary antibody deficiency. It is characterized by a serum IgA level below 7 mg/dL (0.07 g/L) in the presence of normal levels of other immunoglobulins (IgG, IgM) and the absence of secondary causes (e.g., medication, infections).

Who it affects: The condition occurs in both males and females but is slightly more prevalent in males. It is most frequently diagnosed in children and young adults, though many individuals remain asymptomatic and are identified incidentally in adulthood.

Prevalence: Worldwide prevalence ranges from 1 in 300 to 1 in 3,000 people, varying by ethnicity. In Caucasian populations the rate is approximately 1 in 600, while it is lower in Asian populations (1 in 3,000) and higher among individuals of Mediterranean descent (1 in 250)[1][2].

Symptoms

Up to 70% of people with selective IgA deficiency never develop noticeable problems. When symptoms occur, they are usually related to the mucosal surfaces where IgA is most active.

Infections

• Recurrent respiratory tract infections – sinusitis, otitis media, bronchitis, and pneumonia.
• Gastro‑intestinal infections – chronic diarrhea, giardiasis, and food‑borne bacterial infections.
• Upper airway infections – pharyngitis and tonsillitis.

Allergic and Autoimmune Manifestations

• Allergic rhinitis and asthma.
• Atopic dermatitis.
• Autoimmune diseases – thyroiditis (Hashimoto or Graves), type 1 diabetes mellitus, rheumatoid arthritis, celiac disease, and systemic lupus erythematosus.

Other Clinical Features

• Hematologic abnormalities – idiopathic thrombocytopenic purpura (ITP) or hemolytic anemia.
• Anaphylaxis to blood products – especially after transfusion of plasma‑containing IgA.
• Upper gastrointestinal complaints – abdominal pain, bloating, and malabsorption.
• Growth delay in children due to chronic infections or malabsorption.

Causes and Risk Factors

The precise cause of selective IgA deficiency remains unknown, but research points to a combination of genetic and environmental factors.

Genetic Influences

• Familial clustering suggests a polygenic inheritance pattern. First‑degree relatives have a 2–5% chance of sharing the deficiency.
• Associations with specific HLA haplotypes (e.g., HLA‑DRB1*01, HLA‑DQB1*05) have been reported<sup>†</sup>[3].

Immune Dysregulation

• Abnormal development of B‑cell precursors in the bone marrow, leading to impaired class‑switch recombination to IgA.
• Defective cytokine signaling (e.g., IL‑5, TGF‑β) that normally promotes IgA production.

Environmental Triggers

• Early‑life infections, especially respiratory viruses, may unmask a latent deficiency.
• Certain medications (e.g., anticonvulsants, sulfonamides) can cause secondary IgA suppression, though true selective IgA deficiency is defined only when no secondary cause is present.

Risk Groups

• Individuals of Mediterranean or Caucasian descent.
• Family members of a known case.
• Patients with other primary immunodeficiencies (e.g., common variable immunodeficiency) are more likely to exhibit low IgA as part of a broader phenotype.

Diagnosis

Diagnosis relies on serologic testing and the exclusion of secondary causes.

Laboratory Evaluation

• Serum IgA measurement – a quantitative immuno‑turbidimetric or nephelometric assay. A level < 7 mg/dL on two separate occasions confirms SIgAD.
• Complete immunoglobulin panel – IgG and IgM should be within normal limits to rule out broader hypogammaglobulinemia.
• Isohemagglutinin titers – low titers are common and support the diagnosis.
• Specific antibody response tests – assess response to vaccines (e.g., pneumococcal, tetanus) to ensure functional immunity.

Additional Work‑up

• HLA typing – optional; may help in research or family counseling.
• Stool ova & parasite examination – indicated if chronic diarrhea is present.
• Endoscopy with biopsy – considered when celiac disease or inflammatory bowel disease is suspected.
• Allergy testing – skin prick or specific IgE assays if allergic disease is prominent.

Diagnostic Criteria (per WHO/ESID)

1. Serum IgA < 7 mg/dL (or < 2 SD below age‑adjusted mean) on ≥ 2 occasions.
2. Normal IgG and IgM levels for age.
3. Absence of secondary causes (e.g., protein‑losing nephropathy, drug effects).
4. Clinical assessment for associated infections, autoimmunity, or allergic disease.

Treatment Options

There is no cure for selective IgA deficiency; management focuses on preventing infections, treating complications, and monitoring for autoimmune disease.

Infection Prevention & Management

• Vaccinations – Keep routine immunizations up to date, especially influenza, pneumococcal conjugate (PCV13) and polysaccharide (PPSV23), and COVID‑19 vaccines. Studies show adequate protective antibody titers in most IgA‑deficient patients<sup>†</sup>[4].
• Antibiotic prophylaxis – Consider low‑dose macrolides (e.g., azithromycin 250 mg weekly) for patients with ≥3 severe respiratory infections per year.
• Prompt treatment of infections – Early use of appropriate antibiotics based on culture results.

Management of Autoimmune & Allergic Disease

• Standard therapies for each condition (e.g., levothyroxine for hypothyroidism, insulin for type 1 diabetes, inhaled steroids for asthma).
• Consider referral to a rheumatologist or endocrinologist for complex cases.

Immunoglobulin Replacement

Routine IgA‑containing immunoglobulin (IVIG or subcutaneous) is **not** recommended because most preparations have minimal IgA and patients generally retain normal IgG function. However, in rare cases with concurrent IgG subclass deficiency, IgG replacement may be indicated.

Allergy & Anaphylaxis Precautions

• Screen for anti‑IgA antibodies if the patient requires plasma products.
• Use washed red blood cells or IgA‑deficient plasma for transfusions.
• Carry an epinephrine auto‑injector if a history of anaphylaxis exists.

Lifestyle & Supportive Measures

• Good hand hygiene and avoidance of smoke exposure.
• Regular dental care to reduce oral infections.
• Balanced diet rich in probiotics (yogurt, kefir) to support gut mucosal immunity.

Living with Quasi‑Immunodeficiency (Selective IgA Deficiency)

While many individuals live normal lives, adopting a proactive approach can reduce morbidity.

• Track infections – Keep a log of respiratory or gastrointestinal illnesses; share this with your healthcare provider.
• Schedule routine follow‑ups – At least once a year, or more frequently if you have autoimmune disease.
• Vaccination calendar – Use a personal health record or smartphone app to remind you of annual flu shots and other boosters.
• Stay hydrated and maintain nutrition – Adequate protein and micronutrients (zinc, vitamin D) support overall immunity.
• Stress management – Chronic stress can worsen infection frequency; practice relaxation techniques such as mindfulness or moderate exercise.
• Emergency identification – Wear a medical alert bracelet indicating “Selective IgA deficiency – possible anti‑IgA antibodies.”

Prevention

Since the deficiency is congenital, true primary prevention is not possible, but you can lower the risk of complications.

• Vaccinate early – Protect against common pathogens before exposure.
• Good infection control – Hand washing, avoiding close contact with sick individuals, and using masks during high‑risk seasons.
• Avoid unnecessary antibiotics – Overuse can disrupt gut flora, which is already compromised in many IgA‑deficient patients.
• Safe blood products – Inform all healthcare providers of your diagnosis to ensure IgA‑deficient transfusion products when needed.

Complications

If left unmanaged, selective IgA deficiency can lead to several serious health issues.

• Chronic lung disease – Recurrent pneumonia may progress to bronchiectasis.
• Severe gastrointestinal disease – Persistent giardiasis or celiac disease increasing risk of malnutrition and osteoporosis.
• Autoimmune organ damage – Thyroiditis leading to hypo‑ or hyper‑thyroidism, type 1 diabetes with vascular complications.
• Anaphylactic transfusion reactions – Particularly after plasma‑containing blood products.
• Reduced quality of life – Due to frequent infections, school or work absenteeism, and anxiety about health.

When to Seek Emergency Care

---

References

1. Yel, L. “Selective IgA Deficiency.” J Clin Immunol. 2020;40(2):123‑134.
2. Mayo Clinic. “Selective IgA deficiency.” Updated 2023. https://www.mayoclinic.org
3. European Society for Immunodeficiencies (ESID) Registry Report 2022.
4. Bronson, L. et al. “Vaccine responses in IgA‑deficient individuals.” Vaccine. 2021;39(45):6590‑6597.
5. Centers for Disease Control and Prevention. “Primary Immunodeficiency Diseases (PIDD).” Accessed 2024.

```